Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci

Benjamin Howden, Kathryn Holt, H LAM, Torsten Seemann, Susan Ballard, Geoffrey Coombs, Steven Tong, Lindsay Grayson, Paul Johnson, Timothy Stinear

    Research output: Contribution to journalArticleResearchpeer-review

    2 Downloads (Pure)

    Abstract

    Nosocomial outbreaks of vancomycin-resistant Enterococcus faecium (VREfm) are thought to occur by transmission of VREfm between patients, predicting that infection control interventions will limit cross-transmission. Despite implementation of such strategies, the incidence of VREfm infections continues to rise. We aimed to use genomics to better understand the epidemiology of E. faecium within a large hospital and investigate the reasons for failure of infection control strategies. Wholegenome sequencing was performed on 61 E. faecium (36 VREfm) isolates, predominately from blood cultures collected at a single hospital between 1998 and 2009, and on five vanB-positive anaerobic commensal bacteria isolated from human feces. Phylogenomic analysis and precise mapping of the vanB gene, which contains the Tn1549 transposon, showed that at least 18 of the 36 VREfm isolates had acquired the transposon via independent insertion events, indicating de novo generation of VREfm rather than cross-transmission. Furthermore, Tn1549 sequences found in 15 of the 36 VREfm isolates were the same as the Tn1549 sequence from one of the gut anaerobes. National and international comparator E. faecium isolates were phylogenetically interspersed with isolates from our hospital, suggesting that our findings might be globally representative. These data demonstrate that VREfm generation within a patient is common, presumably occurring in the human bowel during antibiotic therapy, and help explain our inability to reduce VREfm infections. A recommendation from our findings is that infection control practices should include screening patients for specific hospital clones of vancomycin-susceptible E. faecium rather than just VREfm. IMPORTANCE Enterococcus faecium is an increasingly important human pathogen causing predominantly antibiotic-resistant infections in hospitalized patients. Large amounts of health care funding are spent trying to control antibiotic-resistant bacteria in hospitals globally, yet in many institutions around the world, vancomycin-resistant E. faecium (VREfm) infections continue to rise. The new findings from this study help explain the failures of our current approaches to controlling vanB VREfm in health care institutions. Given the importance of this bacterium as a cause of hospital-acquired infections and the difficulties faced by infection control units in trying to prevent colonization in their institutions, the novel findings from this study provide evidence that a new approach to controlling VREfm in hospitals is required. In particular, more attention should be given to understanding the epidemiology of hospital-adapted vancomycin-susceptible E. faecium, and patients at higher risk for de novo generation of VREfm need to be identified and optimally managed.
    Original languageEnglish
    Article numbere00412-13
    Pages (from-to)1-9
    Number of pages9
    JournalmBio
    Volume4
    Issue number4
    DOIs
    Publication statusPublished - 2013

    Fingerprint

    Enterococcus faecium
    Infection Control
    Vancomycin-Resistant Enterococci
    Vancomycin
    Anti-Bacterial Agents
    Infection
    Epidemiology
    Bacteria
    Delivery of Health Care

    Cite this

    Howden, B., Holt, K., LAM, H., Seemann, T., Ballard, S., Coombs, G., ... Stinear, T. (2013). Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci. mBio, 4(4), 1-9. [e00412-13]. https://doi.org/10.1128/mBio.00412-13
    Howden, Benjamin ; Holt, Kathryn ; LAM, H ; Seemann, Torsten ; Ballard, Susan ; Coombs, Geoffrey ; Tong, Steven ; Grayson, Lindsay ; Johnson, Paul ; Stinear, Timothy. / Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci. In: mBio. 2013 ; Vol. 4, No. 4. pp. 1-9.
    @article{a1505bc7a3e147d6bf0dd47010ac0613,
    title = "Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci",
    abstract = "Nosocomial outbreaks of vancomycin-resistant Enterococcus faecium (VREfm) are thought to occur by transmission of VREfm between patients, predicting that infection control interventions will limit cross-transmission. Despite implementation of such strategies, the incidence of VREfm infections continues to rise. We aimed to use genomics to better understand the epidemiology of E. faecium within a large hospital and investigate the reasons for failure of infection control strategies. Wholegenome sequencing was performed on 61 E. faecium (36 VREfm) isolates, predominately from blood cultures collected at a single hospital between 1998 and 2009, and on five vanB-positive anaerobic commensal bacteria isolated from human feces. Phylogenomic analysis and precise mapping of the vanB gene, which contains the Tn1549 transposon, showed that at least 18 of the 36 VREfm isolates had acquired the transposon via independent insertion events, indicating de novo generation of VREfm rather than cross-transmission. Furthermore, Tn1549 sequences found in 15 of the 36 VREfm isolates were the same as the Tn1549 sequence from one of the gut anaerobes. National and international comparator E. faecium isolates were phylogenetically interspersed with isolates from our hospital, suggesting that our findings might be globally representative. These data demonstrate that VREfm generation within a patient is common, presumably occurring in the human bowel during antibiotic therapy, and help explain our inability to reduce VREfm infections. A recommendation from our findings is that infection control practices should include screening patients for specific hospital clones of vancomycin-susceptible E. faecium rather than just VREfm. IMPORTANCE Enterococcus faecium is an increasingly important human pathogen causing predominantly antibiotic-resistant infections in hospitalized patients. Large amounts of health care funding are spent trying to control antibiotic-resistant bacteria in hospitals globally, yet in many institutions around the world, vancomycin-resistant E. faecium (VREfm) infections continue to rise. The new findings from this study help explain the failures of our current approaches to controlling vanB VREfm in health care institutions. Given the importance of this bacterium as a cause of hospital-acquired infections and the difficulties faced by infection control units in trying to prevent colonization in their institutions, the novel findings from this study provide evidence that a new approach to controlling VREfm in hospitals is required. In particular, more attention should be given to understanding the epidemiology of hospital-adapted vancomycin-susceptible E. faecium, and patients at higher risk for de novo generation of VREfm need to be identified and optimally managed.",
    keywords = "vancomycin, anaerobe, anaerobic bacterium, antibiotic therapy, article, bacterial gene, bacterial genetics, bacterial infection, bacterial virulence, bacterium isolation, blood culture, commensal, Enterococcus faecium, feces analysis, gene mapping, gene sequence, hospital patient, human, infection control, nonhuman, priority journal, sequence analysis, transposon, treatment failure, vanB gene, vancomycin resistant Enterococcus, vancomycin resistant Enterococcus faecium, vancomycin susceptible Enterococcus faecium, vancomycin susceptible Staphylococcus aureus, Anti-Bacterial Agents, Bacterial Proteins, Chromosome Mapping, Cross Infection, Disease Outbreaks, DNA Transposable Elements, DNA, Bacterial, Genome, Bacterial, Gram-Positive Bacterial Infections, Hospitals, Humans, Molecular Epidemiology, Molecular Sequence Data, Phylogeny, Sequence Analysis, DNA, Vancomycin, Vancomycin Resistance",
    author = "Benjamin Howden and Kathryn Holt and H LAM and Torsten Seemann and Susan Ballard and Geoffrey Coombs and Steven Tong and Lindsay Grayson and Paul Johnson and Timothy Stinear",
    year = "2013",
    doi = "10.1128/mBio.00412-13",
    language = "English",
    volume = "4",
    pages = "1--9",
    journal = "mBio",
    issn = "2150-7511",
    publisher = "American Society for Microbiology",
    number = "4",

    }

    Howden, B, Holt, K, LAM, H, Seemann, T, Ballard, S, Coombs, G, Tong, S, Grayson, L, Johnson, P & Stinear, T 2013, 'Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci', mBio, vol. 4, no. 4, e00412-13, pp. 1-9. https://doi.org/10.1128/mBio.00412-13

    Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci. / Howden, Benjamin; Holt, Kathryn; LAM, H; Seemann, Torsten; Ballard, Susan; Coombs, Geoffrey; Tong, Steven; Grayson, Lindsay; Johnson, Paul; Stinear, Timothy.

    In: mBio, Vol. 4, No. 4, e00412-13, 2013, p. 1-9.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci

    AU - Howden, Benjamin

    AU - Holt, Kathryn

    AU - LAM, H

    AU - Seemann, Torsten

    AU - Ballard, Susan

    AU - Coombs, Geoffrey

    AU - Tong, Steven

    AU - Grayson, Lindsay

    AU - Johnson, Paul

    AU - Stinear, Timothy

    PY - 2013

    Y1 - 2013

    N2 - Nosocomial outbreaks of vancomycin-resistant Enterococcus faecium (VREfm) are thought to occur by transmission of VREfm between patients, predicting that infection control interventions will limit cross-transmission. Despite implementation of such strategies, the incidence of VREfm infections continues to rise. We aimed to use genomics to better understand the epidemiology of E. faecium within a large hospital and investigate the reasons for failure of infection control strategies. Wholegenome sequencing was performed on 61 E. faecium (36 VREfm) isolates, predominately from blood cultures collected at a single hospital between 1998 and 2009, and on five vanB-positive anaerobic commensal bacteria isolated from human feces. Phylogenomic analysis and precise mapping of the vanB gene, which contains the Tn1549 transposon, showed that at least 18 of the 36 VREfm isolates had acquired the transposon via independent insertion events, indicating de novo generation of VREfm rather than cross-transmission. Furthermore, Tn1549 sequences found in 15 of the 36 VREfm isolates were the same as the Tn1549 sequence from one of the gut anaerobes. National and international comparator E. faecium isolates were phylogenetically interspersed with isolates from our hospital, suggesting that our findings might be globally representative. These data demonstrate that VREfm generation within a patient is common, presumably occurring in the human bowel during antibiotic therapy, and help explain our inability to reduce VREfm infections. A recommendation from our findings is that infection control practices should include screening patients for specific hospital clones of vancomycin-susceptible E. faecium rather than just VREfm. IMPORTANCE Enterococcus faecium is an increasingly important human pathogen causing predominantly antibiotic-resistant infections in hospitalized patients. Large amounts of health care funding are spent trying to control antibiotic-resistant bacteria in hospitals globally, yet in many institutions around the world, vancomycin-resistant E. faecium (VREfm) infections continue to rise. The new findings from this study help explain the failures of our current approaches to controlling vanB VREfm in health care institutions. Given the importance of this bacterium as a cause of hospital-acquired infections and the difficulties faced by infection control units in trying to prevent colonization in their institutions, the novel findings from this study provide evidence that a new approach to controlling VREfm in hospitals is required. In particular, more attention should be given to understanding the epidemiology of hospital-adapted vancomycin-susceptible E. faecium, and patients at higher risk for de novo generation of VREfm need to be identified and optimally managed.

    AB - Nosocomial outbreaks of vancomycin-resistant Enterococcus faecium (VREfm) are thought to occur by transmission of VREfm between patients, predicting that infection control interventions will limit cross-transmission. Despite implementation of such strategies, the incidence of VREfm infections continues to rise. We aimed to use genomics to better understand the epidemiology of E. faecium within a large hospital and investigate the reasons for failure of infection control strategies. Wholegenome sequencing was performed on 61 E. faecium (36 VREfm) isolates, predominately from blood cultures collected at a single hospital between 1998 and 2009, and on five vanB-positive anaerobic commensal bacteria isolated from human feces. Phylogenomic analysis and precise mapping of the vanB gene, which contains the Tn1549 transposon, showed that at least 18 of the 36 VREfm isolates had acquired the transposon via independent insertion events, indicating de novo generation of VREfm rather than cross-transmission. Furthermore, Tn1549 sequences found in 15 of the 36 VREfm isolates were the same as the Tn1549 sequence from one of the gut anaerobes. National and international comparator E. faecium isolates were phylogenetically interspersed with isolates from our hospital, suggesting that our findings might be globally representative. These data demonstrate that VREfm generation within a patient is common, presumably occurring in the human bowel during antibiotic therapy, and help explain our inability to reduce VREfm infections. A recommendation from our findings is that infection control practices should include screening patients for specific hospital clones of vancomycin-susceptible E. faecium rather than just VREfm. IMPORTANCE Enterococcus faecium is an increasingly important human pathogen causing predominantly antibiotic-resistant infections in hospitalized patients. Large amounts of health care funding are spent trying to control antibiotic-resistant bacteria in hospitals globally, yet in many institutions around the world, vancomycin-resistant E. faecium (VREfm) infections continue to rise. The new findings from this study help explain the failures of our current approaches to controlling vanB VREfm in health care institutions. Given the importance of this bacterium as a cause of hospital-acquired infections and the difficulties faced by infection control units in trying to prevent colonization in their institutions, the novel findings from this study provide evidence that a new approach to controlling VREfm in hospitals is required. In particular, more attention should be given to understanding the epidemiology of hospital-adapted vancomycin-susceptible E. faecium, and patients at higher risk for de novo generation of VREfm need to be identified and optimally managed.

    KW - vancomycin

    KW - anaerobe

    KW - anaerobic bacterium

    KW - antibiotic therapy

    KW - article

    KW - bacterial gene

    KW - bacterial genetics

    KW - bacterial infection

    KW - bacterial virulence

    KW - bacterium isolation

    KW - blood culture

    KW - commensal

    KW - Enterococcus faecium

    KW - feces analysis

    KW - gene mapping

    KW - gene sequence

    KW - hospital patient

    KW - human

    KW - infection control

    KW - nonhuman

    KW - priority journal

    KW - sequence analysis

    KW - transposon

    KW - treatment failure

    KW - vanB gene

    KW - vancomycin resistant Enterococcus

    KW - vancomycin resistant Enterococcus faecium

    KW - vancomycin susceptible Enterococcus faecium

    KW - vancomycin susceptible Staphylococcus aureus

    KW - Anti-Bacterial Agents

    KW - Bacterial Proteins

    KW - Chromosome Mapping

    KW - Cross Infection

    KW - Disease Outbreaks

    KW - DNA Transposable Elements

    KW - DNA, Bacterial

    KW - Genome, Bacterial

    KW - Gram-Positive Bacterial Infections

    KW - Hospitals

    KW - Humans

    KW - Molecular Epidemiology

    KW - Molecular Sequence Data

    KW - Phylogeny

    KW - Sequence Analysis, DNA

    KW - Vancomycin

    KW - Vancomycin Resistance

    UR - http://www.scopus.com/inward/record.url?scp=84883343175&partnerID=8YFLogxK

    U2 - 10.1128/mBio.00412-13

    DO - 10.1128/mBio.00412-13

    M3 - Article

    VL - 4

    SP - 1

    EP - 9

    JO - mBio

    JF - mBio

    SN - 2150-7511

    IS - 4

    M1 - e00412-13

    ER -

    Howden B, Holt K, LAM H, Seemann T, Ballard S, Coombs G et al. Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci. mBio. 2013;4(4):1-9. e00412-13. https://doi.org/10.1128/mBio.00412-13